ATS 2019 Virtual Final Program

2:15 Introduction: Is High Value Care for COPD Achievable? A.J. Admon, MD, MPH, Ann Arbor, MI 2:30 Thinking Outside the Hospital: The Role of Hospital-at-Home in Reducing Costs of COPD Care C. Echevarria, MD, Newcastle, United Kingdom 2:45 Achieving Value by Delivering NIV for COPD Outside of the ICU L. Myers, MD, Boston, MA 3:00 NIV and How It Can Help the Patient with COPD D. Hart, PhD, Auckland, New Zealand 3:15 Bundled Payments and COPD: An Early Adopter Experience S.P. Bhatt, MD, Birmingham, AL 3:30 An Evolving Bundled Payment for Care Improvement (BPCI) COPD Initiative: Next Steps After Round One V.G. Press, MD, MPH, Chicago, IL 3:45 Organizational Drivers of COPD Readmissions S. Rinne, MD, PhD, Boston, MA 4:00 Impact of the Hospital Readmissions Reduction Program on COPD Readmissions L.C. Feemster, MSc, MD, Seattle, WA CLINICAL • TRANSLATIONAL SCIENTIFIC SYMPOSIUM CME Credits Available: 2 C92 ATS CLINICAL PRACTICE GUIDELINES: CLINICAL PRACTICE ON THE CUTTING EDGE Assemblies on Clinical Problems; Pediatrics; Pulmonary Infections and Tuberculosis; Sleep and Respiratory Neurobiology; Thoracic Oncology; Documents Development and Implementation Committee; Education Committee; Quality Improvement and Implementation Committee 2:15 p.m. - 4:15 p.m. KBHCCD Room C147/C148/C154 (Level 1) Target Audience Physicians, nurses, respiratory therapists, and others who care for adults with interstitial lung disease, malignant pleural effusions, Obesity, OSA, fungal infections and pediatric patients who need supplemental oxygen Objectives At the conclusion of this session, the participant will be able to: • understand how evidence is used to inform diagnostic and treatment recommendations; • apply clinical recommendations from recently published guidelines in clinical practice, improving patient outcomes; • obtain new strategies to managing IPF, Malignant Pleural Effusions, Obesity in OSA, Fungal Infections and pediatric Supplemental Oxygen. This session is proposed as the fifth annual scientific symposium highlighting ATS clinical practice guidelines, as originally requested by the ATS Executive Committee several years ago to highlight recently approved or published ATS evidence-based clinical practice guidelines. This year’s symposium will highlight guidelines and statements on Idiopathic Pulmonary Fibrosis, Malignant Pleural Effusions, Obesity in OSA, Fungal Infections and pediatric Supplemental Oxygen. Speakers will describe the clinical recommendations formulated by the guideline panels, discuss the rationale for each, and critically review the evidence supporting each recommendation. Speakers will also describe how the guidelines provide the foundation for improving care. Speakers include the chairs of the panels that developed the guidelines. Chairing: R.A. Dweik, MD, ATSF, Cleveland, OH C.C. Thomson, MPH, MD, ATSF, Cambridge, MA B. Patel, MD, Houston, TX 2:15 Welcome R.A. Dweik, MD, ATSF, Cleveland, OH 2:20 Grading Strength of Recommendations and Quality of Evidence K.C. Wilson, MD, ATSF, Boston, MA 2:30 Management of Malignant Pleural Effusions D.J. Feller-Kopman, MD, Baltimore, MD 2:50 Management of Obesity for OSA S.R. Patel, MD, Pittsburgh, PA 3:10 Diagnosis of Fungal Infections A.H. Limper, MD, Rochester, MN 3:30 Pediatric Supplemental Oxygen D. Hayes, MD, MS, MEd, ATSF, Columbus, OH 3:50 IPF Diagnosis 2018: Lung Biopsy or Not? -Addressing the ATS-ERS-JRS-ALAT Guideline Recommendation G. Raghu, MD, Seattle, WA 4:10 Closing Remarks B. Patel, MD, Houston, TX BASIC • TRANSLATIONAL MINI SYMPOSIUM C93 MECHANISMS OF AIRWAY INFLAMMATION IN ASTHMA AND COPD 2:15 p.m. - 4:15 p.m. KBHCCD Room D221/D225/D226 (Level 2) Chairing: A. Haczku, MD, PhD, Davis, CA P.A. Verhoef, PhD, MD, Chicago, IL Oral Presentations 2:15 Broader Impact of IL-4R a Blockade than IL-5 Blockade on Mediators of Type 2 Inflammation and Lung Pathology in a House Dust Mite-Induced Asthma Mouse Model/ J. Allinne, G. Scott, D. Birchard, S. Asrat, K. Nagashima, A. Le Floc’h, M.A. Sleeman, A.J. Murphy, J.M. Orengo, Tarrytown, NY, p.A5555 2:30 Airway Basal Cell Notch Signaling Coordinates Immune Cell Localization and Activation in Asthma/ T. Kooistra, A. Pardo-Saganta, K. Discipio, J. Gillis, J.L. Cho, J. Rajagopal, B.D. Medoff, Boston, MA, p.A5556 2:45 MiR-1165-3p Downregulated in Th2 Cells Inhibits Th2 Differentiation in Allergic Asthma by Targeting PPM1A/ M. Huang, Z. Wang, Z. Chen, Nanjing, China, p.A5557 ATS 2019 • Dallas, TX 296 TUESDAY • MAY 21